Innocan Pharma INNPF
OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST

Innocan Pharma (INNPF) Cash from Operations (2024 - 2025)

Updated

Innocan Pharma's Cash from Operations came in at $22,000 for the quarter ended Sep 30, 2025, compared with -$1 million a year earlier and down 96.8% from the prior quarter.

Analysis

Innocan Pharma (INNPF) Cash from Operations (2024 - 2025) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Innocan Pharma reported Cash from Operations of $73,000; for the year ended Dec 31, 2023, it was -$3.9 million.

  • The five-year range for quarterly Cash from Operations is -$1 million (the quarter ended Sep 30, 2024) to $686,000 (the quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 11.40 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 7.72 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 7.61 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.67 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 4.24 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 5.04 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 5.38 Bn
10 Innocan Pharma 5.78 Mn 1.73 Mn 4.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 22,000.00
Jun 30, 2025 686,000.00
Mar 31, 2025 368,000.00
Sep 30, 2024 -1.00 Mn
Jun 30, 2024 675,000.00
Mar 31, 2024 -747,000.00
API Access

Innocan Pharma Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=INNPF&period=max&api_key=YOUR_API_KEY